General Information of Drug (ID: DMTY169)

Drug Name
Norethindrone Drug Info
Synonyms
Activella; Anhydrohydroxynorprogesterone; Anovulatorio; Anovule; Brevicon; Brevinor; Camila; Ciclovulan; Conceplan;Conludaf; Conludag; Demulen; Errin; Estrinor; Ethinylnortestosterone; Ethynylmortestosterone; Ethynylnortestosterone; Gencept; Genora; Gestest; Jenest; Loestrin; Menzol; Microneth; Micronett; Micronor; Micronovum; Milli; Minovlar; Nelova; Nodiol; Noraethisteronum; Noralutin; Norcept; Norcolut; Norcolute; Noresthisterone; Norethadrone; Norethin; Norethindirone; Norethisteron; Norethisterone; Norethisteronum; Norethyndron; Norethynodron; Norethynodrone; Noretisterona; Noretisterone; Norfor; Norgestin; Noriday; Norluten; Norlutin; Norluton; Normapause; Norpregneninlone; Norpregneninolone; Norpregneninotone; Orlest; Proluteasi; Synphase; Triella; Utovlan; Utovlar; Component of Noriday; Norethindrone Norethisterone; Norethindrone [USAN]; Norethisterone [Progestins]; Noretisterone [DCIT]; Primolut N; Brevinor 21; Brevinor 28; Noriday 28; Ortho 1 35; Ortho 7 7 7; Ovysmen 1 35; SC 4640; Synphasic 28; Trinovum 21; Brevinor-1 21; Brevinor-1 28; Camila (TN); Jenest-28; Micronor (TN); Mini-Pe; Mini-pill; Nor-QD; Nora-BE; Norcept-E; Norethin 1/35 E; Norethin 1/50 M; Norethindrone (USP); Norethisterone (JP15); Norethisteronum [INN-Latin]; Noretisterona [INN-Spanish]; Ortho-Novum 1 35; Ortho-Novum 1 50; Ortho-Novum 7 7 7; Ovysmen 0.5 35; Primolut-N; Tri-Norinyl; Ethinyl-19-nortestosterone; Nor-Q.D; Primolut-N (TN); Nor-Q.D.; 17-Ethinyl-19-nortestosterone; 17-Ethynyl-17-hydroxyestr-4-en-3-one; 17-alpha-Ethynyl-19-nortestosterone; 17-alpha-Ethynyl-4-estren-17-ol-3-one; 17-ethynyl-17beta-hydroxyestr-4-en-3-one; 17.alpha.-Ethinyl-19-nortestosterone; 17.alpha.-Ethynyl-19-nortestosterone; 17.alpha.-Ethynyl-4-estren-17-ol-3-one; 17alpha-Ethinyl-19-nortestosterone; 17alpha-Ethynyl-19-nortestosterone; 17alpha-Ethynyl-4-estren-17-ol-3-one; 19-Nor-17-alpha-ethynyltestosterone; 19-Nor-17-ethinyltestosterone; 19-Nor-17.alpha.-ethynyltestosterone; 19-Nor-17alpa-ethynyltestosterone; 19-Nor-17alpha-ethynyltestosterone; 19-Nor-ethindrone; 19-Nor-ethinyl-4,5-testosterone; 19-Norethindrone; 19-Norethinyltestosterone; 19-Norethisterone; 4-Estren-17alpha-ethynyl-17beta-ol-3-one
Indication
Disease Entry ICD 11 Status REF
Acne vulgaris ED80 Approved [1]
Advanced cancer 2A00-2F9Z Approved [1]
Hot flushes GA30 Approved [1]
Menorrhagia GA20.50 Approved [1]
Obsolete atrophic vulva Approved [1]
Solid tumour/cancer 2A00-2F9Z Approved [2]
Endometriosis GA10 Investigative [1]
Therapeutic Class
Contraceptive Agents
Cross-matching ID
PubChem CID
6230
ChEBI ID
CHEBI:7627
CAS Number
68-22-4
TTD ID
D0GL7U
ACDINA ID
D00478

Full List of Drug Formulations Containing This Drug

Norethindrone 0.35 mg tablet
Company Formulation ID FDA Description
A-S Medication Solutions F15499 Anhydrous lactose; D&c yellow no. 10; Magnesium stearate; Talc; Silicon dioxide; Cellulose, microcrystalline; Ethylcelluloses; Povidones; Starch, corn
Central Texas Community Health Centers F15500 Lactose monohydrate; Fd&c yellow no. 6; Magnesium stearate; Povidones; Starch, corn
------------------------------------------------------------------------------------
Norethindrone 5 mg tablet
Company Formulation ID FDA Description
Avera McKennan Hospital; Glenmark Pharmaceutials; Kaiser Foundation Hospitals F15505 Lactose monohydrate; Magnesium stearate; Talc; Silicon dioxide; Cellulose, microcrystalline
Barr Laboratories; Kaiser Foundation Hospitals; Teva Women's Health F15501 Anhydrous lactose; Magnesium stearate; Cellulose, microcrystalline
Aurobindo Pharma F15502 Anhydrous lactose; Magnesium stearate; Cellulose, microcrystalline; Methylene chloride
AvKARE; AvPAK F15503 Lactose; Magnesium stearate; Cellulose, microcrystalline
Amneal Pharmaceuticals F15504 Lactose, unspecified form; Magnesium stearate; Cellulose, microcrystalline
------------------------------------------------------------------------------------

References

1 Norethindrone FDA Label
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015